Revolution Medicines
The Director, GI Analytics will lead the analytics strategy and execution for Revolution Medicines' gastrointestinal cancer portfolio, partnering with cross‑functional teams to generate actionable insights that guide portfolio strategy, launch readiness, and commercial decision‑making. This role requires deep oncology analytics expertise, especially in pancreatic and colorectal cancers, and involves managing data assets, external vendors, and communicating findings to senior leadership.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
19% above the average for this role
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Physician-GI Medical Oncologist
Ochsner Health
Senior or Executive Director, GI Medical Strategy
Erasca
VP Clinical Development and Global Program Lead (GPL) for GI Cancers
Erasca
Associate Director US Oncology Marketing — GI Cancer HCP Strategy & Execution Lead
MSD
Senior Marketing Manager – GI Cancers
AstraZeneca
Registered Nurse
University Health Network